Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?

European Respiratory Journal

Volumn 42, Issue 4, 2013, Pages 888-890

  Coghlan, Gerry ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VASODILATOR AGENT;

CAPILLARY; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; HEART DISEASE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; LEFT HEART DISEASE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; SYSTEMIC SCLEROSIS;

FEMALE; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; MALE; SCLERODERMA, SYSTEMIC;

EID: 84886526949     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00025413     Document Type: Review

References (20)

1. Fox BD, Shimony A, Langleben D, et al. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J 2013; 42: 1083-1091.
2. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792-3800.
3. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-1093.
4. Quinones MA, Gaasch WH, Alexander JK. Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man. Circulation 1976; 53: 293-302.
5. Fujimoto N, Borlaug BA, Lewis GD, et al. Haemodynamic responses to rapid fluid loading: the impact of age, sex and heart failure. Circulation 2013; 127: 55-62.
6. Ling Y, Johnson MK, Kiely DG, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 2012; 186: 790-796.
7. Hurdman J, Condliffe R, Elliot CA, et al. ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre. Eur Respir J 2012; 39: 945-955.
8. Hatano S, Strasser T. Primary Pulmonary Hypertension: Report on a WHO Meeting, Geneva 15-17 October 1973. Geneva, World Health Organization, 1975.
9. GalièN, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537.
10. Leung CC, Moondra V, Catherwood E, et al. Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol 2010; 106: 284-286.
11. Escribano-Subias P, Blanco I, López-Meseguer M, et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J 2012; 40: 596-603.
12. Hachulla AL, Launay D, Gaxotte V, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a crosssectional observational study of 52 patients. Ann Rheum Dis 2009; 68: 1878-1884.
13. Follansbee WP, Miller TR, Curtiss EI, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990; 17: 656-662.
14. Luchsinger PC, Seipp HW Jr, Patel DJ. Relationship of pulmonary artery-wedge pressure to left atrial pressure in man. Circ Res 1962; 11: 315-318.
15. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest 2009; 136: 37-43.
16. Gibson DN, Di Biase L, Mohanty P, et al. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors. Heart Rhythm 2011; 8: 1364-1371.
17. Verel D, Stentiford N. Comparison of left atrial pressure and wedge pulmonary capillary pressure: pressure gradients between left atrium and left ventricle. Br Heart J 1970; 32: 99-103.
18. Frost AE, Farber HW, Barst RJ, et al. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mmHg: insights from the REVEAL registry. Chest 2013; 143: 185-195.
19. Naeije R, Vachiery JL, Yerly P, et al. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 2013; 41: 217-223.
20. Tatebe S, Fukumoto Y, Sugimura K, et al. Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease. Circ J 2012; 76: 1235-1244.